Skip to main content
. 2021 Apr 7;21(6):448. doi: 10.3892/ol.2021.12709

Figure 1.

Figure 1.

Association between protein levels of EGFRs and RECIST after cetuximab therapy. (A) EGFR, (B) ErbB2 and (C) ErbB3. EGFR, epidermal growth factor receptor; PD, progressive disease; PR, partial response; SD, stable disease; RECIST, response evaluation criteria in solid tumors.